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Orderly Process of Sequential Cytokine Stimulation Is Required for
Activation and Maximal Proliferation of Primitive Human Bone Marrow
CD34" Hematopoietic Progenitor Cells Residing in G0
By Amy C. Ladd, Robert Pyatt, Andre Gothot, Susan Rice, Jon McMahel, Christie M. Traycoff,
and Edward F. Srour
Bone marrow (BM) CD34" cells residing in the G0 phase of divisions, respectively, by the end of the 14-day period. Re-
gardless of the cytokine used for primary stimulation,cell cycle may be the most suited candidates for the exami-
nation of cell cycle activation and proliferation of primitive G0CD34" cells moved only to phase II by day 7, whereas a
substantial percentage of cells incubated with SCF or FLhematopoietic progenitor cells (HPCs). We designed a dou-
ble simultaneous labeling technique using both DNA and remained in phase I. Cells cultured in SCF or FL for the entire
14-day period did not progress beyond phase III but prolifer-RNA staining with Hoechst 33342 and Pyronin Y, respec-
tively, to isolate CD34" cells residing in G0(G0CD34" ). Using ated into phase IV (with Ú20% of cells remaining in phases
I and II) if IL-3, but not IL-6, was substituted for either cyto-long-term BM cultures and limiting dilution analysis,
G0CD34" cells were found to be enriched for primitive HPCs. kine on day 7. G0CD34" cells incubated with IL-3 for 14 days
proliferated the most and progressed into phase IV; how-In vitro proliferation of G0CD34" cells in response to sequen-
tial cytokine stimulation was examined in a two-step assay. ever, when SCF was substituted on day 7, cells failed to
proliferate into phase IV. Most intriguing was a group ofIn the first step, cells received a primary stimulation con-
sisting of either stem cell factor (SCF), Flt3-ligand (FL), in- cells, many of which were CD34", detected in cultures ini-
tially stimulated with IL-3, which remained as a distinct pop-terleukin-3 (IL-3), or IL-6 for 7 days. In the second step, cells
from each group were washed and split into four or more ulation, mostly in G0/G1, unable to progress out of phase II
regardless of the nature of the second stimulus received ongroups, each of which was cultured again for another week
with one of the four primary cytokines individually, or in day 7. A small percentage of these cells expressed cyclin
E, suggesting that their proliferation arrest may have beencombination. Tracking of progeny cells was accomplished
by staining cells with PKH2 on day 0 and with PKH26 on day mediated by a cyclin-related disruption in cell cycle. These
results suggest that a programmed response to sequential7. Overall examination of proliferation patterns over 2 weeks
showed that cells could progress into four phases of prolifer- cytokine stimulation may be part of a control mechanism
required for maintenance of proliferation of primitive HPCsation. Phase I contained cytokine nonresponsive cells that
failed to proliferate. Phase II contained cells dividing up to and that unscheduled stimulation of CD34" cells residing in
G0 may result in disruption of cell-cycle regulation.three times within the first 7 days. Phases III and IV consisted
of cells dividing up to five divisions and greater than six q 1997 by The American Society of Hematology.
H of transcription and accumulation of RNA. Although pro-EMATOPOIETIC STEM cells, and most likely primi-tive hematopoietic progenitor cells (HPCs), are be- gression into active phases of cell cycle and subsequent pro-
lieved to reside in a metabolically and mitotically dormant liferation is a normal process for most active somatic cells,
state within the bone marrow (BM) microenvironment.1-3 In such a process may be detrimental for the hematopoietic
the context of the cell cycle, these cells, therefore, lie dor- potential of primitive HPCs because activation and prolifera-
mant within the specialized resting stage of G1 known as tion of these cells may proceed along two different paths.5
G0. Cells residing in G0 are metabolically inactive almost to The first is believed to result in the generation of progeny
the extent of a complete shut-down of protein synthesis.4 cells possessing identical functional properties to the original
Cellular activation induces exit of cells from G0 and entry cells, a process known as self-renewal. Cells proceeding
into G1, a phase of the cell cycle characterized by initiation along the second path undergo proliferation-associated dif-
ferentiation and lineage commitment, an irreversible process
resulting in the loss of these cells from the pool of primitive
From the Division of Hematology/Oncology and Indiana Elks HPCs. Mechanisms leading to activation of stem cells and
Cancer Research Center, Department of Medicine and the Depart- their subsequent decision to commit to either self renewal
ment of Pediatrics, Herman B Wells Center for Pediatric Research, or to differentiation remain unresolved. Paramount in the
Indiana University School of Medicine, Indianapolis, IN. lack of our understanding of these mechanisms is the diffi-Submitted November 19, 1996; accepted March 24, 1997.
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versity School of Medicine, 975 West Walnut Street, IB 442, India- proven to be enriched for primitive HPCs, at the time of
napolis, IN 46202-5121. isolation, these cells were mitotically heterogeneous. Mitotic
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90% of isolated cells being quiescent, these cells resided in
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such, studies aiming at examining cytokine-mediated activa-q 1997 by The American Society of Hematology.
0006-4971/97/9002-0013$3.00/0 tion and progression of dormant cells into active phases of
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selected CD34/ cells were stained with FITC-conjugated CD34cell cycle were not possible because the target population
(BDIS). Cells were sorted as previously described6 on a FACStarplusconsisted of cells at different levels of activation and cyto-
flow cytometer (BDIS) to yield total CD34/ cells. Sorted CD34/kine responsiveness. Still, examination of the effects of he-
cells were immediately stained with Hst and PY, as described pre-matopoietic growth factors and cytokines on proliferation
viously, and sorted on a FACStarplus. The front laser of the
and differentiation of HPCs allowed for a general classifica- FACStarplus provided 40 mW of 488 nm light to excite PY while
tion of these mediators as early- or late-acting cytokines.5 the back Krypton laser was tuned to deliver 50 mW of 350 nm
We speculated that to examine hematopoietic cell activation ultraviolet (UV) light to excite Hst. Both signals were collected on
and the direct effects of individual cytokines on cell cycle a linear scale and were used to generate a dual parameter dot plot
progression of dormant HPCs, it was essential to obtain mi- (Fig 1). With the Hst signal displayed on the X-axis, a typical DNA
histogram could be generated with cells residing in G0/G1 phases oftotically homogeneous populations of cells, preferably in G0.
the cell cycle appearing in a discrete peak. Within this peak, cellsDiscrimination between G0 and G1 is possible if DNA
in deep G0 displayed little RNA staining and were, therefore, identi-staining is coupled with RNA labeling.9 Such an approach
fied as those displaying dim PY staining along the Y axis. Cells inallows for the identification of cells beginning to transcribe
G1, which had more RNA, stained brighter and were higher than G0and accumulate RNA as they progress from G0 into G1.
cells along the Y axis (Fig 1). A small sorting window, constructedPyronin Y (PY) is an RNA-specific dye that has been suc-
to contain approximately 5% of the cells (Fig 1), was established
cessfully used for two parameter cell-cycle analyses.10 We for the collection of G0 cells taking care to exclude dead cells.
combined Hst and PY staining to identify human marrow Another window containing 5% to 10% of the cells was constructed
CD34/ cells residing in G0 at the time of isolation. In this at the top of the G0/G1 peak to collect cells in the G1 phase of cell
report we show that these cells were highly enriched for cycle. Viability and purity of sorted cells always exceeded 98% and
95%, respectively. During staining, sorting, plating, and during atprogenitor cells displaying primitive hematopoietic proper-
least the next 2 days, cells stained with Hst and PY were kept awayties. In addition, G0CD34/ cells were successfully used in
from direct light. Isolation of BM CD34/ HLA-DR0 CD150 cellsactivation and proliferation experiments in which it was pos-
was accomplished by staining cells with allophycocyanin-conjugatedsible to identify the need for an organized sequential delivery
CD34 (Caltag Laboratories, Burlingame, CA), FITC-conjugatedof activation signals to ensure maximum proliferation poten-
HLA-DR, and phycoerythrin (PE)-conjugated CD15 (BDIS). Atial. Furthermore, unscheduled activation signals appeared FACScan (BDIS) was used for flow cytometric analysis.
to arrest the proliferation of these cells even after resumption Staining with PKH2 and PKH26. When needed, sorted
of scheduled signals. G0CD34/ cells were stained with PKH2 (Sigma ImmunoChemicals)
before their use in short-term culture as per manufacturer’s instruc-
MATERIALS AND METHODS tions and as previously described.12 Briefly, cells were suspended in
1 mL of diluent and immediately transferred into a polypropyleneCollection and fractionation of human bone marrow CD34/
tube containing 1 mL of 4 1 1006 mol/L PKH2 in diluent at roomcells. Human BM aspirates were collected from normal adult
temperature. After 5 minutes of incubation with frequent agitation,volunteers after obtaining informed consent according to guide-
2 mL of FBS were added to the suspension for 1 minute. The totallines established by the Human Investigation Committee of the
volume was brought up to 8 mL with complete medium (Iscove’sIndiana University School of Medicine. Low density BM cells
modified Dulbecco’s medium [IMDM] supplemented with 10%were separated over Ficoll/Hypaque (Pharmacia, Piscataway, NJ)
FBS, L-glutamine, and antibiotics [penicillin, 100 U/mL and strepto-and then enriched by immunomagnetic selection for CD34/ cells,
mycin, 100 mg/mL]), and the cells were washed three times in com-as previously described.11 All reagents for the immunomagnetic
plete medium. All of the complete medium ingredients (except forseparation procedure were kindly provided by Baxter Healthcare,
FBS) were obtained from BioWhitaker, Walkersville, MD. After theSanta Ana, CA. Enriched CD34/ cells were stained on ice for 20
first wash, cells were transferred to a new tube. After the third wash,minutes with fluorescein isothiocyanate (FITC)-conjugated anti-
cells were resuspended in complete medium and seeded in short-CD34 (Becton Dickinson Immunocytometry Systems [BDIS], San
term culture as described next. A sample of PKH2-stained CD34/Jose, CA), or isotype-matched nonspecific myeloma proteins for
cells was fixed in 1% paraformaldehyde immediately after stainingcontrols. Cells were washed and resuspended for flow cytometric
to be used 7 or 14 days later for the determination of day 0 greencell sorting in phosphate-buffered saline (PBS) supplemented with
fluorescence intensity. Staining of cultured (PKH2-stained cells)1% human serum albumin.
with PKH26 was performed as described previously for PKH2, sub-Hst and PY staining. CD34/ cells sorted to homogeneity as
stituting the former for the latter. A sample of PKH26-stained cellsdescribed below were stained with Hst (Molecular Probes, Eugene,
was fixed in 1% paraformaldehyde immediately after staining to beOR) and PY (Sigma Chemical Company, St Louis, MO, catalog
used 7 days later for the determination of green and red fluorescencenumber 9172) according to the following procedure. Hst was pre-
intensities corresponding to day 7.pared at 1.6 mmol/L in Hst buffer consisting of Hanks Balanced Salt
Limiting dilution analysis (LDA). Determination of the fre-Solution supplemented with 20 mmol/L HEPES, 1 g/L glucose, and
quency of long-term hematopoietic culture-initiating cell (LTHC-IC)10% fetal bovine serum (FBS; Hyclone, Logan, Utah) with the pH
by stromal cell-free LDA was performed as previously described.12adjusted to 7.2 while PY was prepared in the same buffer to deliver
Briefly, populations of freshly isolated CD34/ cells, or subsets ofa final concentration of 1 mg/mL. Sorted CD34/ cells were washed
CD34/ cells were seeded at 64, 32, 16, and 8 cells in 100 mL oftwice in Hst buffer and resuspended in 1.5 mL of 1.6 mmol/L Hst
complete medium supplemented with 200 ng/mL stem cell factorsolution (up to 5 1 106 cells). Cells were incubated in a 377C water
(SCF), 25 ng/mL interleukin-3 (IL-3), 25 ng/mL IL-6, 10 ng/mLbath for 45 minutes, at which time PY was added to the cells without
granulocyte-macrophage colony-stimulating factor (GM-CSF), andany prior washing and the incubation continued for another 45 min-
2 U/mL erythropoietin into the wells of flat-bottomed 96-well platesutes. Cells were washed once in excess Hst buffer before sorting.
in replicates of 48 wells per cell dose. Plates were incubated at 377COne sample stained with Hst only and another stained with PY only
in 100% humidified atmosphere containing 5% CO2 and fed withwere prepared as control.
Flow cytometric analysis and cell sorting. Immunomagnetically another 100 mL of complete medium and cytokines on day 7. On
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Fig 1. Dot plot and single parameter histograms
of a typical Hoechst 33342 (X axis) and Pyronin Y (Y
axis) staining of bone marrow CD34" cells. CD34"
cells were first sorted to homogeneity, then stained
with Hst and PY as described in Materials and Meth-
ods. The single parameter histograms are shown
here to elucidate the contribution of each stain to
the formation of the dot plot. The DNA/RNA staining
shown in this figure was derived from a cultured (7
days with SCF, IL-3, and IL-6) BM sample of CD34"
cells to elaborate the S/G2 "M population for better
definition of all three phases of cell cycle. Sort win-
dows R1, R2, and R3 shown in the dot plot represent
the windows used to collect G0, G1, and S/G2 " M
cells, respectively. R4 designates the area in such a
dot plot where dead cells are located.
day 14, a total of 120 mL of medium were removed from each well Cell cycle analysis. Cell fractions were stained for cell cycle
analysis as previously described.12 Briefly, cells were stained withfollowed by the addition of 150 mL of a mixture designed to deliver
at a final concentration, 30% FBS, 1.1% methylcellulose, 5 1 1005 equal volumes of staining buffer (0.1 mg/mL propidium iodide /
0.6% Nonidet P-40 in PBS) and 2 mg/mL RNAse, agitated, andmol/L 2-mercaptoethanol, 100 ng/mL SCF, 25 ng/mL IL-3, 25 ng/
mL IL-6, 25 ng/mL GM-CSF, and 2 U/mL erythropoietin. Cells incubated on ice for 30 minutes in the dark. Samples were analyzed
on a FACScan flow cytometer calibrated with chicken erythrocytes.were mixed into the semisolid medium by gentle vortexing, and the
plates were incubated as described previously. On day 28, the plates The percentage of cells in G0/G1 phases of cell cycle was analyzed
using Modfit software (Verity Software House, Topsham, ME).were scored under an inverted microscope for the presence of burst-
forming unit-erythroid (BFU-E), colony forming unit-granulocyte- Two dimensional cell tracking in vitro. Activation and prolifera-
tion of G0CD34/ cells in response to sequential exposure to singlemacrophage (CFU-GM) or colony forming unit-mixed (CFU-
GEMM) in every well. Wells were considered positive, indicating or multiple cytokines was analyzed by two-dimensional cell tracking.
Sorted G0CD34/ cells were stained on day 0 with PKH2 as describedthe presence of at least one LTHC-IC in the original cell inoculum
deposited into the well, if one or more hematopoietic colonies per previously. Individual wells of a flat-bottomed 48-well plate (Falcon
#3072, BDIS) were seeded with 2 1 104 up to 4 1 104 PKH2-well were detected. The number of negative wells per cell dose input
was then calculated and the data used in a x-minimalization assay13 stained G0CD34/ cells in 1 mL of complete medium. Individual
wells were supplemented with either 200 ng/mL SCF, 20 ng/mLto calculate a frequency of LTHC-IC.
Long-term hematopoietic cell cultures. Long-term hematopoi- Flt-3 ligand, 100 ng/mL IL-3, or 100 ng/mL IL-6. All cytokines
used in these studies, except Flt-3 ligand, were a kind gift frometic cultures (LTHC) were initiated with 2 1 103 to 2 1 104 sorted
CD34/, G0CD34/, G1CD34/, or CD34/ HLA-DR0 CD150 cells. Amgen (Thousand Oaks, CA). Flt-3 ligand was a kind gift from
Immunex (Seattle, WA). The plates were incubated in 100% humidi-Cultures were established in 1 mL of complete medium in flat-
bottomed 48-well plates as previously described.14 At initiation, and fied 5% CO2 in air at 377C, and these cytokines were replenished
every 48 hours until day 7. On day 7, cells from each well wereevery 48 hours thereafter, cultures were supplemented with 200 ng/
mL SCF, 100 ng/mL IL-3, and 100 ng/mL IL-6. At weekly intervals, collected separately, washed three times, and each group of cells
was stained with PKH26. Each group of cells was then split intocultures were demidepopulated by removal of half the cells followed
by the addition of fresh medium and cytokines. Harvested cells were four or more new wells and each well received the same or a new
single or multiple cytokine combination as indicated in Results. Cellscounted and assayed for their clonogenic progenitor cell content as
described next. were incubated and supplemented with appropriate cytokines for an
additional 7 days under the same conditions. On day 14, all the cellsHematopoietic progenitor cell assays. Cells (1 1 103 freshly
sorted cells or between 2 1 103 to 5 1 104 cultured cells/mL) were harvested and analyzed on a FACScan for residual PKH2 and
PKH26 using samples fixed on day 0 and day 7 to establish originalwere suspended in duplicate in plastic 35-mm tissue culture dishes
containing 1 mL 30% FBS, 5 1 1005 mol/L 2-mercaptoethanol, fluorescence intensities. In some experiments, groups of cells identi-
fied by their proliferation history as assessed by retention of both1.1% methylcellulose, 100 ng/mL SCF, 25 ng/mL IL-3, 25 ng/mL
IL-6, 25 ng/mL GM-CSF, and 2 U/mL erythropoietin in IMDM. membrane dyes (see Results for details) were sorted for further
analysis.Cultures were incubated in 100% humidified 5% CO2 in air at 377C.
After 14 days BFU-E, CFU-GM, and CFU-GEMM were enumerated Flow cytometric analysis of cyclin E and p27. Fractions of cul-
tured cells were first isolated by flow cytometric cell sorting basedusing an inverted microscope.
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Fig 2. Dot plot display of a typical Hoechst 33342 (X axis) and Pyronin Y (Y axis) staining of fresh bone marrow CD34" cells (A). The three
sort windows R1, R2, and R3 were constructed to collect G0, G1, and S/G2 " M cells, respectively. After sorting, G0, G1, and S/G2 " M cells,
along with unsorted total CD34" cells were stained with propidium iodide and analyzed for their cell-cycle distribution as described in Materials
and Methods. B depicts the cell cycle distribution of total freshly isolated BM CD34" cells with only 11% being in S/G2 " M. C, D, and E
illustrate the DNA content of sorted G0, G1, and S/G2 " M cells, respectively. As can be seen, no cells were detected with greater than 2n
DNA among G0 and G1 cells (C and D, respectively), whereas all sorted S/G2 " M cells displayed a DNA content characteristic of their position
in the cell cycle (E).
on their proliferative history in the two-dimensional cell tracking (Fig 2). In addition, we examined CD34/ cells isolated in
experiments. Cells were then fixed and stained as previously de- different stages of the cell cycle for their expression of the
scribed by Farahat et al.15 Briefly, cells were fixed for 10 minutes nuclear antigen Ki67.16,17 Expression of this nuclear antigen
at room temperature in 2 mL of a 1:1 mixture of 4% paraformalde- was least among cells isolated as G0 and highest amonghyde in PBS and Becton Dickinson (BDIS) fluorescence-activated those sorted as S/G2/M with G1 cells displaying an interme-cell sorting lysing solution prepared in distilled water as per the diate Ki67 expression (data not shown).
manufacturer’s recommendations. Cells were then centrifuged,
Because of its reported toxicity,9 different PY concentra-washed in 0.5% Tween 20 in PBS, and incubated for 20 minutes at
tions were evaluated before adopting a final working concen-room temperature with the primary anticyclin E or anti-p27 mono-
tration. Only at concentrations lower than 5 mg/mL was via-clonal antibodies (Pharmingen, San Diego, CA). The cells were
then washed twice and developed with a PE-Cy5–conjugated goat bility consistently maintained above 95%. Therefore, a final
antimouse IgG1 monoclonal antibody (Caltag Laboratories, South working concentration of 1 mg/mL was chosen. It has been
San Francisco, CA). Control samples were stained with irrelevant reported that at concentrations lower than 5 mmol/L (1.51
mouse IgG1. mg/mL), PY preferentially stains mitochondrial membranes
in lieu of RNA. To confirm that when used at 1 mg/mL, PY
RESULTS
will stain RNA and not just mitochondrial membranes, cells
Isolation of CD34/ cells residing in G0 . Exit of cells treated with RNase then stained with PY were compared
from G0 and entry into G1 is associated with transcription with cells stained with PY without RNase treatment. PY
of RNA, which can be measured by RNA-specific dyes such fluorescence intensity of CD34/ cells treated with RNase
as PY.10 When PY was used in conjunction with Hst, it was was significantly lower than that of control cells, thus, veri-
possible to generate a dot plot in which G0 cells were identi- fying the RNA-specificity of PY staining performed under
fied as those with 2n DNA and minimal RNA content (Fig these conditions (data not shown).
1). This allowed for the identification of a group of cells Activation and progression of G0CD34/ cells into active
constituting approximately 5% to 10% of the total cells ana- phases of cell cycle. We hypothesized that G0CD34/ cells
lyzed, which were isolated as G0CD34/ cells. To confirm may be less responsive to cytokine stimulation and may
the cell-cycle status of isolated G0CD34/ cells, these cells require a longer period of time to traverse into active phases
were stained with propidium iodide and analyzed. An excess of cell cycle than mitotically heterogeneous populations of
of 99% of G0CD34/ cells were detected within the G0/G1 primitive HPCs, such as CD34/ HLA-DR0 CD150 cells.
phases of cell cycle (Fig 2). Similarly, cells isolated as G1 Both groups of cells were plated in suspension cultures sup-
or as S/G2 / M cells contained the appropriate amount of plemented with SCF, IL-3, and IL-6 and were monitored
periodically for their cell-cycle status. Whereas CD34/DNA corresponding to their respective phases of cell cycle
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Fig 3. Cell tracking in vitro of cultured bone marrow G0CD34" cells using the membrane dye PKH2. G0CD34" cells were isolated, stained
with PKH2, and cultured in IMDM containing 10% FCS in the presence of SCF, IL-3, and IL-6 for 7 days. A sample fixed in 1% paraformaldehyde
on day 0 (A) was used to identify the fluorescence intensity corresponding to freshly stained cells. On day 7, cells were harvested and stained
with either a PE-conjugated isotype control monoclonal antibody (B) or PE-conjugated CD34 (C). Samples were analyzed for PKH2 (X axis)
and PE (Y axis) fluorescence to estimate the fraction of CD34" cells remaining as CNR cells. As can be seen in C, 83% of cultured cells remained
CD34", and 16% could be identified as CNR cells.
HLA-DR0 CD150 cells responded within 16 to 18 hours to of production of progenitor cells was detected by week 4
in cultures initiated with CD34/ HLA-DR0 CD150 cellscytokine stimulation and began to exit G0/G1, more than
95% of G0CD34/ cells remained nonresponsive to cytokine compared with those initiated with CD34/ cells (Fig 4).
However, peak production of assayable progenitors instimulation for at least 24 hours, suggesting that G0CD34/
cells are more quiescent than CD34/ HLA-DR0 CD150 cells G0CD34/ cultures did not occur until week 5 when a 95-
fold increase in the number of input clonogenic cells wasand less responsive to cytokine stimulation.
We recently reported on a group of quiescent HPCs termed detected. Production of progenitor cells in these cultures was
still detectable by week 7 (Fig 4).cytokine nonresponsive (CNR) cells, which, in vitro, appear
to resist cytokine stimulation and remain dormant for several
days.12 We examined whether the frequency of CNR cells
is higher in cultures initiated with G0CD34/ cells than what
was previously established for cultures of total CD34/
cells.12,18 As can be seen in Fig 3, after 7 days of exposure
to SCF, IL-3, and IL-6, 16% of cultured G0CD34/ cells
tracked with PKH2 expressed the same level of PKH2 stain-
ing observed on day 0 confirming the cytokine nonrespon-
sive status of these cells. We have previously shown, that
under the same culture conditions, less than 5% of cultured
total CD34/ cells remain as CNR cells.12,18 This percentage
of CNR cells among G0CD34/ cells suggested once again
the primitive and quiescent nature of these cells.
Functional properties of G0CD34/ cells. The hemato-
poietic potential of G0CD34/ cells was assessed in two dif-
ferent assays. In the first, our previously described stromal
cell-free–limiting dilution analysis assay12 was used to cal-
culate the frequency of LTHC-IC among CD34/ and
G0CD34/ cells. In eight separate experiments, the mean
Fig 4. A representative experiment depicting the total productionLTHC-IC frequency among CD34/ cells was 2.3 { 1.4, a of assayable progenitor cells (BFU-E plus CFU-GM, plus CFU-GEMM)
value similar to what we previously reported for BM CD34/ in long-term bone marrow cultures initiated with freshly isolated
total CD34" (h) G0CD34" (%), G1CD34" (l), and CD34" HLA-DRÏ CD15Ïcells.12,18 However, a significantly higher (P .01) statistical
(l) BM cells. Cultures were maintained by the addition every 48mean of LTHC-IC was documented for G0CD34/ cells (4.0
hours of SCF, IL-3, and IL-6 as described in Materials and Methods.{ 2.5), indicating that this group of cells is enriched for
Every week, half of the cultured cells were removed and assayed forprimitive HPCs. In the second approach, the ability of clonogenic progenitor cells as described in Materials and Methods.
CD34/, G0CD34/, G1CD34/, and CD34/ HLA-DR0 CD150 The total production of clonogenic progenitors at every time point
was calculated using the formula X ! (number of clonogenic cellscells to sustain in vitro hematopoiesis was evaluated in
per culture) # (1/2)n, where ‘‘X’’ is the number of total colonies inLTHC.14,19CD34/ cells maintained the production of
culture and ‘‘n’’ is equal to the number of previous demidepopu-
assayable progenitors for up to 4 weeks (Fig 4), whereas lations. All results were normalized to reflect those obtained from
G1CD34/ cells sustained progenitor cell production for 1 cultures initiated with 104 sorted cells. Identical results were obtained
in four other experiments.additional week. On the other hand, a 10.2-fold higher level
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Fig 5. Estimation of the number of divisions attained by G0CD34" cells in a two-dimensional tracking experiment. G0CD34" cells were
stained with PKH2 on day 0 and cultured for 14 days in the presence of IL-3. On day 7, cells were harvested and stained with PKH26 and
analyzed (A). The dark vertical and horizontal lines in all three dot plots represent the lower limits of the fluorescence intensities of PKH2 and
PKH26, respectively, achieved directly after staining. Using the relative PKH2 fluorescence loss (50% loss with every division along the X axis),
it was possible to identify the position of these cells after every division. Thus, cells moving into phase II (upper left hand corner of dot plot)
had been through one, two, or three divisions by day 7. Panel B, which was generated on day 14, depicts the same cells previously shown in
A after they were allowed to proliferate for an additional week. The relative positions of the vertical lines designating one, two, and three
divisions are still in place. Notice how dividing cells ‘‘track’’ along a 457 diagonal direction because both green and red dyes are lost proportion-
ally as the cells divide, such that cells proliferating beyond three divisions now appear below the dark horizontal line representing the lower
limit of PKH26 fluorescence. Panel C, which is composed of the same dot plot shown in B, illustrates how divisions 4, 5, 6, and 7 achieved
between days 8 and 14 can be calculated along the Y axis using loss of PKH26 for measurement. Phase III cells were identified as those having
gone through four or five divisions, and phase IV cells were defined as those having divided in excess of six times. Proliferation of cells
compromising phases II, III, and IV was defined as depicted in Fig 6.
Fig 6. Definition of phases II, III, and IV of G0CD34" cells in two-dimensional tracking experiments using sequential cytokine stimulation.
Sorted cells were stained with PKH2 on day 0 and maintained with either FL or SCF for the first 7 days of culture. On day 7, cells were washed
and stained with PKH26 (two dot plots on the left). After that, cells were split and cultured with different cytokines as indicated to the right.
Cells traversing to the upper left hand corner were identified as phase II cells (see Fig 5). Cells receiving SCF as the secondary stimulus (middle
column) were capable of few additional divisions only and, therefore, defined phase III cells. For ease of distinction, phase III cells were colored
red. When cultured cells received IL-3 for a secondary stimulus (right two dot plots), few additional divisions beyond phase III were demonstra-
ble. Cells capable of proliferating six or more times (see Fig 5) defined phase IV cells. For ease of distinction, phase IV cells were colored in
blue. Dot plots used for this illustration were from the same experiment depicted in Fig 7.
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Sequential cytokine stimulation. Given the dormant na- divisions or greater than six divisions, respectively, by the
end of the 14-day period (Fig 5). These patterns of divisionsture of G0CD34/ cells (Fig 3), we speculated that these cells
may be excellent targets for the examination of cell cycle were established from examining the proliferation history of
cells stimulated with sequential additions of single early/lateactivation and proliferation of primitive HPCs in response
to sequential cytokine stimulation. A two-step assay system or late/early5 cytokine combinations during the primary and
secondary stimulation periods (Fig 6). The extent of prolifer-was employed in which proliferation during the primary
stimulation period was tracked with PKH2, and continued ation after 7 days of primary stimulation defined phase II
cells, which, as seen in Fig 6, would have divided up toproliferation or arrest of cultured cells was tracked in the
secondary stimulation period with PKH26. Because 50% of three times. Cells exposed to SCF for the entire 14-day cul-
ture period underwent only two additional cell divisions (Figeither membrane dye is lost to daughter cells with every cell
division, the relative fluorescence of stained cells could be 6), thus defining phase III cells as those dividing between
four and five times (Fig 5). Cells stimulated with either FLused to infer the number of divisions that the cells had been
through (Fig 5). or SCF during the first 7 days then exposed to IL-3 during
the secondary stimulation period underwent maximal prolif-Overall examination of proliferation patterns of these cells
for 2 weeks showed that cells could progress into four phases eration by day 14 (Fig 6) and, therefore, defined phase IV
cells as those dividing up to or in excess of seven divisionsof proliferation. Phase I contained cytokine nonresponsive
cells, which failed to proliferate (Fig 5). Phase II contained (Fig 5).
Examination of the pattern of proliferation induced bycells dividing up to three times within the first 7 days. Phases
III and IV consisted of cells dividing between four and five different cytokine stimulation showed that regardless of the
Fig 7. A representative experiment depicting sequential cytokine stimulation of G0CD34" cells in a two-dimensional tracking experiment.
Sorted G0CD34" cells were stained with PKH2 on day 0 and cultured for 7 days (day 0-7, on the left) in the presence of one primary cytokine.
On day 7, cells were harvested, washed, stained with PKH26, and cultured for an additional 7 days (day 7-14) in the presence of the secondary
cytokine/cytokine combinations indicated to the right. Definition of phase III and IV cells, depicted here as red and blue events, respectively,
was accomplished according to criteria described in Fig 6. A total of nine such experiments were performed with similar results obtained in
all. However, because of the relatively small number of G0CD34" cells obtained from a normal donor, FL was used in four experiments only,
and IL-6 was used in only three experiments. SCF and IL-3 were used in all nine experiments.
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Table 1. Percentage of Phase II and Phase III Plus IV Cells Residing were residing in G0/G1, suggesting the inability of these
in G0/G1 After 14 Days of Sequential Cytokine Stimulation cells to continue to proliferate after traversing into phase II.
When IL-3 was included in the secondary stimulus of cellsPercentage of Cells in G0/G*1
Cytokine Treatment: Day 0-7/Day 7-14 exposed to SCF or FL between days 0 and 7, a substantial
fraction of phase III and IV cells were detected in S/G2 /
Phase SCF/SCF IL-3/FL IL-3/SCF FL/IL-3 SCF/IL-3 / SCF M phases of cell cycle (Table 1). Almost one third (34%)
II 92 93 92 88 81 of phase II cells still expressed CD34 (data not shown),
III and IV 92 86 84 69 76 suggesting that the proliferative potential of these cells was
* Sorted G0 CD34/ cells were cultured under sequential cytokine not exhausted. In contrast, only 8% of cells progressing into
stimulation as indicated for a period of 14 days. Phase II and phase phases III and IV remained CD34/ by day 14 (data not
III plus IV cells were sorted on day 14, stained with propidium iodide, shown). These findings prompted us to examine the role of
and analyzed for cell cycle status. Results shown were derived from cyclins and cyclin/cyclin-dependent kinase (cdk) inhibitors
one representative experiment out of three. Similar results were ob- in the cell-cycle regulation of these cells. Figure 8 depicts
tained in the other two experiments. All experiments contained the
cyclin E and p27 expression of phase II and phase III andsame cytokine combinations shown in the first four columns.
IV cells isolated from a culture receiving IL-3 as the primary
stimulus and IL-3 plus FL as the secondary stimulus. As can
be seen in Fig 8, a similar percentage of phase II and phasecytokine used for primary stimulation, G0CD34/ cells moved
III and IV cells expressed the cyclin-cdk inhibitor p27 (81%only to phase II by day 7, and a substantial percentage of
and 90%, respectively). In contrast, whereas 70% of phasecells remained in phase I (Fig 7) showing the cytokine nonre-
III and IV cells expressed cyclin E, only 38% of phase IIsponsive nature of a fraction of these cells. Cells cultured
cells expressed this cyclin suggesting that proliferation ofin SCF for the entire 14-day period did not progress beyond
these cells may be arrested via a mechanism involving thephase III but proliferated into phase IV (with 20% of cells
downregulation of the expression of cyclin E rather than theremaining in phases I and II) if IL-3, but not IL-6, was
upregulation or over-expression of p27.substituted for either cytokine on day 7 (Fig 7). Also, cells
receiving FL as a primary stimulus followed by a secondary
DISCUSSIONstimulus of IL-3 or IL-6 behaved in an analogus manner to
In this communication, we described a new technique forthose exposed to SCF between days 0 and 7. The same
the isolation of primitive, dormant HPCs from human BMeffects observed with IL-3 alone were observed if the combi-
and began to explore mechanisms and kinetics of prolifera-nation of IL-3 plus IL-6 was substituted for FL or SCF on
tion of mitotically ‘‘synchronized’’ cells in response to indi-day 7, suggesting that these cytokines had distinct, and not
vidual, as well as sequential cytokine stimulation. Most, ifadditive or synergistic effects. G0CD34/ cells incubated with
not all previous studies attempting to examine cell-cycleIL-3 for 14 days proliferated the most and progressed into
progression of primitive human HPCs were hampered byphase IV; however, when SCF was substituted on day 7,
the mitotic heterogeneity of test cells because the selectioncells failed to proliferate into phase IV. In fact, under all
criteria of these cells had not been based on mitotic quies-conditions examined, neither SCF nor IL-6 were capable of
cence of isolated cells. Cells of phenotypically homogeneouspromoting proliferation of G0CD34/ cells into phase IV.
populations of HPCs, such as CD34/ CD380 20,21CD34//c-Similarly, in experiments in which FL was used as a second-
kitlow/CD38neg/low,22 or CD34/ HLA-DR0 14,23,24 are usuallyary stimulus, proliferation of G0CD34/ cells into phase IV
defined as dormant only because the majority of these cellswas not demonstrable regardless of the nature of the primary
reside in G0/G1. Such cell cycle status determinations arestimulus (data not shown). Most intriguing was a group of
usually made after the phenotypic selection of target cellscells detected in cultures initially stimulated with IL-3, which
using strategies that are neither suitable for the discrimina-remained as a distinct population unable to progress out of
phase II regardless of the nature of the secondary stimulus tion between G0 and G6,251 nor capable of maintaining cell
viability.16,17 Recently, Goodell et al26 described an elegantreceived on day 7. Phase II cells were also apparent in other
cultures, but were most prominent in cultures maintained approach for the isolation of primitive murine HPCs using
different emission properties of Hst and went on to showwith IL-3 during the first 7 days. It is important to stress
that the magnitude of proliferation of G0CD34/ cells during that less than 2% of cells within this unique side population
(SP) were in S/G2 /M. Because, in these studies, propidiumthe first 7 days, especially in response to IL-3, was varied
in as much as expected from inter- and intra-individual varia- iodide was used to examine the cell-cycle status of isolated
SP cells, again no insight into the proportion of cells residingtion of primary cells. However, the general trend of prolifera-
tion patterns in all experiments, under all conditions tested, in G0 versus those in G1 could be gained.
In our studies, and probably for the first time, mitoticallywas consistent with that depicted in Fig 7.
Proliferation arrest of phase II G0CD34/ cells. To better homogeneous cells residing in the most dormant phase of
the cell cycle, namely G0, were used for proliferation kineticsunderstand the nature of G0CD34/ cells arrested in phase II
after 14 days in culture, their cell cycle status and continued studies. It is important to point out that human or mu-
rine HPCs isolated by other methods, such as rhodamineexpression of CD34 were examined. Furthermore, possible
mechanisms responsible for the proliferation arrest of these 1236,27-30 or Hst and rhodamine 1237,8, may also be mitoti-
cally homogeneous. However, no solid proof to this effectcells were investigated. As can be seen in Table 1, a high
percentage of phase II cells isolated from different cultures was presented in these previous studies, and if so,25 no dis-
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Fig 8. Expression of cyclin E (left histogram) and p27 (right histogram) among phase II and phase III plus IV cells isolated from sequential
cytokine stimulation of G0CD34" cells in a two-dimensional tracking experiment. Cells were sorted based on their PKH2 and PKH26 fluorescence
as defined in Fig 6 from cultures receiving IL-3 as a primary stimulus and SCF or FL as a secondary stimulus. Phase II cells were those shown
in Figs 5, 6, and 7 as green events, and phases III plus IV were those shown as red and blue events, respectively. Cells belonging to Phases
III and IV were collected together. Cells were stained for cyclin E and p27 as described in Materials and Methods. Each histogram is an overlay
of three separate files derived from the analysis of isotype staining (- - - - -), phase II cells ( ) and phase III plus IV cells ( ). Positive
values for every marker, obtained after background subtraction, are indicated. Similar data were obtained in two other experiments.
tinction between the G0 versus G1 status of rhodaminelo cells cytokines. Using double tracking of cultured cells, we were
able to identify two types of proliferation signals. The first,was attempted. The simplicity of the procedure we described
in this study makes it possible to subfractionate any pheno- a proliferation progression signal, was capable of initiating
proliferation and progression through cell cycle and sus-typically defined population of cells, including subsets of
CD34/ cells, into the different phases of cell cycle, thus taining proliferation through a limited number of cell divi-
sions. All four cytokines examined delivered proliferationmaking the investigations into cell cycle regulation of stem
cells more accessible. Given that the only commonly used progression signals. The second, a proliferation competence
signal, was required to sustain maximal proliferation and tofluorescence channel occupied by this technique is the ‘‘red’’
(FL2) channel and that Hst is excited with UV light, any propel cells into phase IV. Only IL-3 delivered proliferation
competence signals. The degree of proliferation achievednumber of fluorochrome combinations could still be avail-
able for the isolation of phenotypically defined fractions of during 14 days in response to different cytokines, and conse-
quently, whether a given cytokine delivers proliferation com-CD34/ cells before their restaining with Hst and PY.
Cells isolated with this technique were not only homoge- petence signals cannot be explained by the length of cell
cycle of G0CD34/ cells under the influence of various cyto-neous as far as their cell cycle status is concerned, but were
also highly enriched for dormant cells possessing primitive kine stimulation. Tanaka et al38 showed that SCF was more
efficient than IL-3 in reducing the time required for HPCshematopoietic activity. A sizable fraction of G0CD34/ cells
remained dormant over a period of 7 days persisting in cul- to traverse through G1, suggesting that, if capable, cells un-
der the influence of SCF would undergo a higher number ofture as CNR cells. The fraction of CNR cells present among
G0CD34/ cells was higher than we previously reported for cell divisions than those exposed to IL-3. Our studies do not
support such an observation. Both SCF and IL-3, when pres-total CD34/ cells12 and also higher than that surviving in
vitro suicide as determined by Berardi et al.31 In addition, ent in culture for the entire 14-day period, were capable
of inducing a similar number of division cycles allowingG0CD34/ cells were also enriched for LTHC-IC and for
cells capable of initiating and sustaining in vitro hematopoie- G0CD34/ cells to proceed through four or five divisions.
However, only IL-3 sustained maximal proliferation of SCFsis, two in vitro measurements that have long been recog-
nized as indicators of primitive hematopoietic progenitor or or FL prestimulated G0CD34/ cells, an observation in line
with that of Tanaka et al38 who showed that after a 5-daystem cell activity.12,19,32-37
Proliferation is an integral component of differentiation primary stimulation of murine HPCs with SCF and IL-11,
‘‘as a single factor, IL-3 was most effective in support ofand maturation of elements of the hematopoietic system. If
responsiveness of HPCs to mediators of proliferation, such secondary colonies,’’ suggesting that SCF or FL alone did
not provide a proliferation competence signal. Noteworthy inas cytokines and growth factors, is key to initiation of prolif-
eration and progression through cell cycle, then it stands to our observations, is that no additional proliferation potential
capable of propelling dividing cells beyond phase IV wasreason that a better understanding of these events can be
achieved if the effects of single cytokines on dormant, mitoti- observed when cells were stimulated with all four cytokines
between days 7 and 14 compared with that achieved withcally homogeneous cells are examined. We gain insight into
initiation and maintenance of proliferation of G0CD34/ cells IL-3 alone, suggesting again that only IL-3 in this cytokine
combination provided proliferation competence signals.by the examination of sequential stimulatory effects of single
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Our studies appear to confirm earlier reports regarding the cyclin E complex. Because phase II cells appeared to be
arrested in G0/G1, we investigated the expression, or lackeffects of early cytokines such as FL and SCF on quiescent
HPCs. Under our experimental conditions, all three cyto- thereof, of cyclin E and p27 among phase II cells. Our results
suggest that unscheduled proliferation competence signalskines examined, FL, SCF, and IL-3, were capable of initiat-
ing, and to different magnitudes, sustaining the proliferation received by a subset of G0CD34/ cells result in the disruption
of cell-cycle regulation possibly via a mechanism involvingof G0CD34/ cells. SCF alone sustained cycling and prolifer-
ation of human BM and cord blood CD34/ cells.16 Shah et the downregulation of expression of cyclin E.
Activation and proliferation of G0CD34/ cells in responseal21 showed that FL induced substantial proliferation of early
CD34/ CD380 BM progenitors. Similar results, using the to different cytokines showed that, although these cells are
mitotically homogeneous, they remain functionally heteroge-same phenotype of HPC, CD34/ CD380 cells, were reported
by Petzer et al.39 In addition, these investigators detected neous. Studies in the murine system showed that phenotypi-
cally homogeneous HSC candidates isolated using differentsimilar, albeit to a lesser degree, stimulatory activity by
SCF.39 On the other hand, other investigators40 failed to de- techniques25,26 consist of cells belonging to different phases
of the cell cycle. These studies went on to establish thattect any cycling of CD34/ CD380 cells when examined as
a fraction of cultured total CD34/ cells. However, these quiescent primitive HPCs (G0/G1) provided a higher degree
of radioprotection than their cycling (S/G2 / M) counter-observations were restricted to the first 48 hours of culture.40
Although unexpected, IL-3 profoundly stimulated the prolif- parts25 or to confirm that, regardless of their mitotic status,
primitive HPCs possessed equivalent long-term engraftmenteration of G0CD34/ cells, an observation previously reported
by Petzer et al.39 In fact, IL-3 was found to be superior to potential.26 Our studies seem to take this controversy a step
further by suggesting that even cells isolated from within aFL and SCF as a single agent in increasing the number of
colony-forming cells among cultured CD34/ CD380 cells, very specific phase of cell cycle are composed of subgroups
of primitive HPCs with varying degrees of dormancy, cyto-an event that is directly associated with proliferation and
increase in cell numbers.39 The novelty of our present studies kine responsiveness, and hematopoietic potential. One plau-
sible explanation for this observation is that G0CD34/ cellslies in the fact that our experimental design allowed us to
distinguish between the ability of a given cytokine to initiate most likely contain progeny of differentiating HPCs dividing
in vivo, which, at the time of isolation, had traversed throughproliferation and promote progression through cell cycle ver-
sus the capacity to maintain and sustain these activities. In mitosis and re-entered G0. Such a group of cells, although
mitotically identical to other cells within G0CD34/ cells,addition, the technique of double tracking of dividing cells
afforded a unique opportunity to investigate whether an or- would be functionally distinct from more primitive HPCs.
In conclusion, we have described a novel approach forderly sequence of cell cycle progression and proliferation
competence signals is required for support of maximal prolif- the isolation of mitotically homogeneous CD34/ cells en-
riched for primitive HPCs. This technique, which can easilyeration of primitive HPCs.
At first glance, it was possible to conclude that IL-3 was distinguish between cells residing in different stages of cell
cycle, may be a powerful tool for the examination of cell-capable of sustaining maximal proliferation of G0CD34/
cells. However, closer examination of the pattern of prolifer- cycle activation and regulation of hematopoietic cells and to
investigate cell-cycle–associated events in these cells. Usingation of G0CD34/ cells maintained in IL-3 for 14 days
showed that a sizable fraction of cells were unable to pro- this methodology, we examined initiation of proliferation
and progression through cell cycle of CD34/ cells residinggress beyond phase II, a stage of proliferation in our experi-
ments equivalent to up to 4 divisions. Phase II cells pro- in G0 in response to sequential individual cytokine stimula-
tion. Our results suggest that orderly activation of CD34/ceeded successfully into phases III and IV if the original
cells residing in G0 and a programmed response to sequentialproliferation stimulus resulted from exposure to SCF or FL.
cytokine stimulation may be part of a control mechanismIL-6, as reported by several investigators21,39 was unable to
required for maintenance of proliferation of primitive HPCs.promote sustained proliferation but appeared to be capable
These studies also suggest that unscheduled stimulation ofof delivering the necessary proliferation progression signals
primitive HPCs may result in disruption of cell cycle regula-required for resumption of proliferation in response to com-
tion, possibly through altered expression of cell-cycle stage-petence signals. Examination of the mechanisms responsible
specific cyclins. Such findings may prove to be important infor the proliferation arrest of phase II cells showed the possi-
the areas of ex vivo expansion and retrovirus-mediated geneble involvement of cyclin-induced disruption of cell-cycle
transfer.regulation.
Cyclins are integral components of cell-cycle regulation,
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